RDS--CPAP or surfactant or both.
Acta Paediatr
; 101(464): 24-8, 2012 Apr.
Article
en En
| MEDLINE
| ID: mdl-22404888
ABSTRACT
UNLABELLED There is mounting evidence that early continuous positive airway pressure (CPAP) from birth is feasible and safe even in very preterm infants. However, many infants will develop respiratory distress syndrome (RDS) and require surfactant treatment. Combining a non-invasive ventilation approach with a strategy for surfactant administration is important, but questions remain about the optimal timing, mode of delivery and the value of predictive tests for surfactant deficiency. CONCLUSION:
Early CPAP in very preterm infants is as safe as routine intubation in the delivery room. However, a strategy for surfactant administration should be part of a non-invasive ventilation approach for those infants at risk of developing significant RDS.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Síndrome de Dificultad Respiratoria del Recién Nacido
/
Surfactantes Pulmonares
/
Recien Nacido Prematuro
/
Presión de las Vías Aéreas Positiva Contínua
Tipo de estudio:
Prognostic_studies
Límite:
Humans
/
Newborn
Idioma:
En
Revista:
Acta Paediatr
Año:
2012
Tipo del documento:
Article
País de afiliación:
Suecia